Newsroom

Sorted by: Latest

-

Franklin Templeton Announces 19(a) Notices for Closed-End Municipal Funds

BOSTON--(BUSINESS WIRE)--The 19(a) monthly distribution notices for Putnam Managed Municipal Income Trust (NYSE: PMM) and Putnam Municipal Opportunities Trust (NYSE: PMO) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. A...
-

Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 44th Annual J.P Morgan Healthcare Conference on January 14, 2026 at 9:45 a.m. PT. A live webcast of the presentation will be available on the Establishment Labs...
-

America250 Launches America Gives to Make 2026 the Biggest Year of Service in American History

WASHINGTON--(BUSINESS WIRE)--America250, the official nonpartisan organization established by Congress to lead the nation’s 250th anniversary commemoration, today launched its latest tentpole program, America Gives, a nationwide initiative designed to make 2026 the largest year of volunteerism in U.S. history. America Gives challenges businesses, nonprofits, schools, youth groups, faith-based networks, and organizations of all kinds to commit to increasing their volunteer efforts and measurable...
-

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of results from subgroup analyses of the phase 3 FOCUS study. The publication, titled “Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma” was published in the Journal of Cancer...
-

Franklin Templeton Announces 19(a) Notices for Closed-End Taxable Funds

BOSTON--(BUSINESS WIRE)--The 19(a) monthly distribution notices for Putnam Master Intermediate Income Trust (NYSE: PIM) and Putnam Premier Income Trust (NYSE: PPT) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. Putnam Master Intermediate Income Trust estimates that $0.0131 per share of Putnam Master Intermediate Income Trust’s dividend is paid from accumulated net inv...
-

Spondyloarthritis (Spondyloarthropathy) Global Clinical Trials Review 2025: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for i...